Ferring Pharmaceuticals

12 FDA enforcement records linked to this company.

• recall — Class II2023-07-05

  cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

• recall — Class II2021-04-07

  Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

• recall — Class II2021-04-07

  Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.

• recall — Class III2021-03-17

  Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP

• recall — Class I2020-08-26

  Superpotent Drug

• recall — Class I2020-08-26

  Superpotent Drug

• recall — Class I2020-08-26

  Superpotent Drug

• recall — Class III2015-10-21

  Subpotent Drug

• recall — Class III2014-07-16

  Discoloration; due to prolonged heat exposure.

• recall — Class II2014-06-25

  Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.

• recall — Class III2013-04-10

  Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A

• recall — Class III2012-12-12

  Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.